The Levothyroxine Odyssey: Navigating the Path of Survivorship in Thyroid Cancer
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Kim M, Lee J, Hyun M, Song Y
. Risk of Subsequent Primary Cancers in Thyroid Cancer Survivors according to the Dose of Levothyroxine: A Nationwide Cohort Study. Endocrinol Metab (Seoul). 2024; 39(2):288-299.
PMC: 11066454.
DOI: 10.3803/EnM.2023.1815.
View
2.
Zhang H, Yang Y, Gao C, Tian L
. Effect of Thyroid-Stimulating Hormone Suppression Therapy on Cardiac Structure and Function in Patients With Differentiated Thyroid Cancer After Thyroidectomy: A Systematic Review and Meta-Analysis. Endocr Pract. 2023; 30(2):177-186.
DOI: 10.1016/j.eprac.2023.11.006.
View
3.
Goldfarb M, Franco A
. Survivorship, Quality of Life, and Transition to Adult Care for Pediatric and Adolescent Thyroid Cancer Survivors. Thyroid. 2022; 32(12):1471-1476.
DOI: 10.1089/thy.2022.0407.
View
4.
Kress E, Samarut J, Plateroti M
. Thyroid hormones and the control of cell proliferation or cell differentiation: paradox or duality?. Mol Cell Endocrinol. 2009; 313(1-2):36-49.
DOI: 10.1016/j.mce.2009.08.028.
View
5.
Obeid L, Dhillon H, Tan S, Vardy J
. Is there a need for change in cancer survivorship care? A qualitative exploration of survivor experiences and needs at the Sydney Cancer Survivorship Centre Clinic. Support Care Cancer. 2023; 31(12):642.
PMC: 10584705.
DOI: 10.1007/s00520-023-08102-w.
View